Deutsche Bank AG Sells 234,549 Shares of Shire PLC (SHPG)

Deutsche Bank AG reduced its stake in Shire PLC (NASDAQ:SHPG) by 81.1% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 54,733 shares of the biopharmaceutical company’s stock after selling 234,549 shares during the period. Deutsche Bank AG’s holdings in Shire were worth $9,520,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds also recently bought and sold shares of SHPG. Kepos Capital LP increased its holdings in shares of Shire by 400.0% during the 3rd quarter. Kepos Capital LP now owns 425,000 shares of the biopharmaceutical company’s stock worth $77,040,000 after buying an additional 340,000 shares during the last quarter. Pacer Advisors Inc. increased its holdings in shares of Shire by 13.4% during the 3rd quarter. Pacer Advisors Inc. now owns 6,452 shares of the biopharmaceutical company’s stock worth $1,170,000 after buying an additional 761 shares during the last quarter. Her Majesty the Queen in Right of the Province of Alberta as represented by Alberta Investment Management Corp acquired a new stake in shares of Shire during the 3rd quarter worth $3,096,000. Neuberger Berman Group LLC increased its holdings in shares of Shire by 12.8% during the 3rd quarter. Neuberger Berman Group LLC now owns 167,050 shares of the biopharmaceutical company’s stock worth $30,281,000 after buying an additional 18,898 shares during the last quarter. Finally, NorthCoast Asset Management LLC increased its holdings in shares of Shire by 1.9% during the 3rd quarter. NorthCoast Asset Management LLC now owns 96,290 shares of the biopharmaceutical company’s stock worth $17,455,000 after buying an additional 1,785 shares during the last quarter. Institutional investors own 20.23% of the company’s stock.

NASDAQ SHPG remained flat at $$179.20 during trading hours on Friday. Shire PLC has a 1-year low of $123.73 and a 1-year high of $182.47. The company has a market capitalization of $54.71 billion, a P/E ratio of 11.83, a PEG ratio of 1.54 and a beta of 0.87. The company has a current ratio of 0.92, a quick ratio of 0.51 and a debt-to-equity ratio of 0.36.

ILLEGAL ACTIVITY WARNING: “Deutsche Bank AG Sells 234,549 Shares of Shire PLC (SHPG)” was first published by Baseball Daily News and is the property of of Baseball Daily News. If you are accessing this story on another website, it was illegally copied and reposted in violation of United States and international copyright law. The original version of this story can be viewed at https://www.baseballdailydigest.com/news/2019/05/11/shire-plc-shpg-shares-sold-by-deutsche-bank-ag.html.

Shire Company Profile

Shire plc, a biotechnology company, researches, develops, licenses, manufactures, markets, distributes, and sells medicines for rare diseases and other specialized conditions worldwide. The company offers products in therapeutic areas, including hematology, genetic diseases, neuroscience, immunology, internal medicine, ophthalmology, and oncology.

Read More: 52-Week High/Low Prices For Stock Selection

Institutional Ownership by Quarter for Shire (NASDAQ:SHPG)

Receive News & Ratings for Shire Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Shire and related companies with MarketBeat.com's FREE daily email newsletter.